PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
NCT06673017
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma
Borderline Resectable Pancreatic Adenocarcinoma
Locally Advanced Pancreatic Adenocarcinoma
Pancreatic Cancer
Interventions
DRUG:
PTM-101
Sponsor
PanTher Therapeutics